Scandinavian Journal of Surgery最新文献

{"title":"Novel minimal invasive antireflux techniques: A systematic review.","authors":"Marcus Reuterwall Hansson, Alexandros Tsoposidis, Apostolos Analatos, Lars Lundell, Srdjan Kostic, Anders Thorell, Bengt Håkanson","doi":"10.1177/14574969251385759","DOIUrl":"10.1177/14574969251385759","url":null,"abstract":"<p><strong>Introduction: </strong>New transoral and minimally invasive techniques for the treatment of gastroesophageal reflux disease (GERD) have emerged, warranting evaluation of their clinical efficacy and safety.</p><p><strong>Methods: </strong>A literature review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines. Based on the available amount of information about clinical efficacy, the review was restricted to Stretta, Esophyx/TIF, MUSE (Medigus ultrasonic surgical endostapler), LINX, and RefluxStop procedures.</p><p><strong>Results: </strong>In total, 86 original studies evaluating the efficacy and safety of second-generation antireflux techniques were identified. The study populations are well described in which GERD is objectively verified. For Stretta, data were available from four double-blind, sham-controlled, randomized studies (RCT) albeit with a short follow-up time. Cohort-based data on 24-h pH monitoring, proton pump inhibitor (PPI) consumption, and QoL demonstrated a clinically significant long-term effect. For the Esophyx technique, two double-blind, sham-controlled randomized studies with 12 months of follow-up are available, which together with prospective cohort studies with longer follow-up demonstrate a sustained effect. The corresponding long-term effects of MUSE transoral technique need to be defined. The scientific documentation behind the LINX technique is incomplete, but data show the same level of efficacy in terms of objective assessments as for Esophyx. The scientific evidence for RefluxStop is still meager but promising.</p><p><strong>Conclusions: </strong>Both Esophyx and LINX seem to provide long-lasting symptom control with normalization of QoL in patients with chronic GERD. This seems to be true for patients with small hiatal hernia who responded well to treatment with PPI. MUSE and RefluxStop™ need better documentation to define their future role in clinical practice.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"235-243"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145402568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cholecystectomy or non-operative management for cholecystitis in elderly patients: An analysis based on hospital practice patterns.","authors":"Maria Söderström, Olov Norlén, Fredrik Linder, Erik Osterman","doi":"10.1177/14574969261431971","DOIUrl":"10.1177/14574969261431971","url":null,"abstract":"<p><strong>Background and aims: </strong>Early cholecystectomy improves outcomes in acute cholecystitis, yet surgeons often hesitate to operate on elderly and multimorbid patients, and prospective data in this group are lacking. This cohort study compared outcomes across hospitals with differing operative policies to estimate the effect of surgery among the elderly.</p><p><strong>Methods: </strong>Retrospective data using the Swedish National Inpatient Register, including 12,481 patients aged ⩾ 70 years treated for cholecystitis between 2015 and 2019, were analyzed. Outcomes included all-cause and gallstone-related mortality, length of stay related to gallstone disease during the index admission, and within 1 and 3 years. Hospitals and counties were categorized into quartiles based on cholecystectomy rates (Q1 = lowest, Q4 = highest). Survival was assessed using Cox proportional hazards regression. Length of stay was analyzed with linear regression.</p><p><strong>Results: </strong>Patients treated at Q1 hospitals were slightly older but had similar comorbidity burdens compared to Q4 hospitals. Surgical rates ranged from 25% to 60%. Overall mortality was lower in Q4 counties, but not significantly different at hospital level (hazard ratio (HR) = 0.86 95% confidence interval (CI) = 0.77-0.96). Gallstone-related mortality did not differ across quartiles. Although the index admission length of stay was similar, cumulative length of stay at 1 and 3 years was shorter for patients treated at Q4 hospitals compared to Q1 (0.87 fewer days at 3 years; 95% CI = 0.39-1.34).</p><p><strong>Conclusions: </strong>Hospitals with higher cholecystectomy rates did not demonstrate lower mortality, but regions with higher surgical rates showed improved survival. Higher operative rates were associated with fewer recurrences and reduced cumulative length of stay, suggesting that increased use of cholecystectomy benefits both patients and healthcare systems.</p><p><strong>Clinical trial registration: </strong>Not applicable.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"177-184"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147482348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Shared decision-making in the treatment of uncomplicated gallstone disease: A cross-sectional pilot study.","authors":"Martin Alavi Treider, Simone Kienlin, Thomas J Fyhn, Tom Glomsaker, Magnus Fasting, Jürgen Kasper, Tom Mala","doi":"10.1177/14574969261419688","DOIUrl":"10.1177/14574969261419688","url":null,"abstract":"<p><strong>Background and aims: </strong>Shared decision-making (SDM) is increasingly emphasized in clinical guidelines. For uncomplicated gallstone disease, both surgical and conservative strategies are considered safe, making patient preferences central to treatment selection. This study assessed the extent of patient involvement in decision-making regarding treatment for uncomplicated gallstone disease.</p><p><strong>Methods: </strong>In this prospective pilot study conducted at a surgical outpatient clinic in Norway, all referred patients with uncomplicated gallstone disease were invited to participate. Video-recorded consultations were independently evaluated by two expert raters. Surgeons, patients, and experts completed the MAPPIN-SDM questionnaire. The MAPPIN-SDM score is calculated as the mean of 11 items (0-4), with higher scores indicating greater SDM.</p><p><strong>Results: </strong>Of 34 eligible patients, 26 were included; 68% were women, and the mean age was 47.8 years (SD = 16.1). The overall mean MAPPIN-SDM score was 2.6 (SD = 0.48). Patients (mean = 3.5, SD = 0.48) and surgeons (mean = 2.9, SD = 0.56) rated the level of SDM higher than external observers (mean = 1.55, SD = 0.65; p < 0.001). Fourteen patients (54%) ultimately underwent surgery. Their average MAPPIN-SDM score was significantly higher than that of managed conservatively (2.89 versus 2.28, p < 0.001).</p><p><strong>Conclusion: </strong>This study demonstrates a moderate level of SDM in consultations for uncomplicated gallstone disease but reveals considerable discrepancies between patient/surgeon perceptions and observer assessments. Higher SDM scores were associated with the choice of surgery. These findings highlight the need for targeted strategies to improve the quality and consistency of SDM in the management of uncomplicated gallstone disease.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"169-176"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Accuracy and reliability of preoperative CT in perforated diverticulitis: Post hoc secondary analysis from the SCANDIV trial.","authors":"Johannes K Schultz, Johanna M Sigurdardottir, Linda T Backstad, Arnar Thorisson, Sheraz Yaqub, Abbas Chabok, Tom Øresland, Peter M Lauritzen","doi":"10.1177/14574969261418419","DOIUrl":"10.1177/14574969261418419","url":null,"abstract":"<p><strong>Background and aims: </strong>Undetected cancers and fecal contamination in perforated diverticulitis may lead to failure of laparoscopic lavage. This study aimed to evaluate the diagnostic accuracy of preoperative computed tomography (CT) examinations and the interobserver agreement for detecting colonic malignancy and fecal contamination in patients with perforated diverticulitis.</p><p><strong>Methods: </strong>This study included 198 patients with suspected perforated diverticulitis from the SCANDIV trial, randomized to laparoscopic lavage or primary resection. CT examinations of all patients were independently reviewed by two specialists in abdominal radiology, and features of fecal contamination and colonic malignancy were registered and compared to the surgical reports.</p><p><strong>Results: </strong>At surgery, fecal contamination was described in 33 patients and was diagnosed on CT in 7 of those by both radiologists (sensitivity = 21%, specificity = 96%, positive predictive value (PPV) = 50%, and negative predictive value (NPV) = 86%) and in 25 patients by at least one of the radiologists (sensitivity = 76%, specificity = 63%, PPV = 29%, and NPV = 93%). Interobserver agreement between radiologists was 64% for fecal contamination (kappa = 0.18, SE = 0.05; p < 0.001). In 7 of 12 patients who turned out to have colon cancer, this was suspected at CT by at least one radiologist (sensitivity = 58%, specificity = 91%, PPV = 29%, NPV = 97%). Interobserver agreement between radiologists for suspected colonic malignancy was 92% (kappa = 0.46; SE = 0.12; p < 0.001).</p><p><strong>Conclusion: </strong>In this selected cohort of patients with suspected perforated diverticulitis, re-evaluation of CT scans proved unreliable for detecting malignancies and fecal contamination. This suggests that preoperative CT cannot replace follow-up colonoscopy or colonography following laparoscopic lavage.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"137-146"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146203399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Baseline risk factors for split-thickness skin graft failure: A retrospective cohort study.","authors":"Eve Kinnunen, Johanna Raukola, Paavo Paajanen, Jenny Lopez, Fausto Biancari, Jussi Repo, Kristiina Hietanen","doi":"10.1177/14574969261416624","DOIUrl":"10.1177/14574969261416624","url":null,"abstract":"<p><strong>Background and objective: </strong>Split-thickness skin grafting is a common procedure for the treatment of complicated wounds. Predictors of skin graft failure are not fully understood. The study aimed to identify baseline predictors of skin graft failure and delayed healing.</p><p><strong>Methods: </strong>Consecutive adult patients with wounds treated using split-thickness skin grafting between 2009 and 2019 were included in a retrospective single-center study. Failures referred to total graft loss or the need of a new operation.</p><p><strong>Results: </strong>In total, 1484 wounds in 1011 patients were analyzed. Graft failure occurred in 384 (25.9%) cases and reoperation was required in 297 (20.0%) cases. At 1 year, the wound was healed in 91.5% of the cases. Logistic regression analysis showed that peripheral arterial disease, diabetes, use of immunosuppressive medication, and wounds located in the foot significantly increased the risk of graft failure, while wounds located in the chest and those secondary to trauma, burn, or cancer excision had significantly lower graft failure risk. Cox proportional hazards analysis showed that wounds of the hand, forearm, and thigh as well as those secondary to trauma and burns were associated with higher rates of wound healing at 1 year. Wounds in feet, wound duration, lower limb edema, peripheral arterial disease, use of antipsychotic medication as well as wounds secondary to surgical complications, venous insufficiency, diabetes, and other comorbidities were associated with lower wound healing at 1 year.</p><p><strong>Conclusions: </strong>The present study identified several risk factors associated with poor outcome after skin grafting. These findings highlight the importance of recognizing patient comorbidities and wound etiology in preoperative planning.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"194-202"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146167703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Breast MRI in ductal carcinoma in situ (DCIS) of the breast in clinical practice.","authors":"Saara Turtiainen, Irina Rinta-Kiikka, Ilkka Koskivuo","doi":"10.1177/14574969261420935","DOIUrl":"10.1177/14574969261420935","url":null,"abstract":"<p><strong>Background and aims: </strong>Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer with increasing incidence in recent decades. Early detection and accurate staging of DCIS are crucial for determining the appropriate treatment approach, with breast-conserving surgery (BCS) being the standard when feasible. The role of preoperative magnetic resonance imaging (MRI) in DCIS remains controversial, particularly in relation to its potential to identify incidental findings that may influence surgical decisions. This study aims to evaluate the clinical value of preoperative MRI in patients with pure DCIS, focusing on its impact on surgical management and the potential influence of incidental findings on mastectomy rates.</p><p><strong>Material and methods: </strong>A retrospective review of 91 patients with pure DCIS who underwent preoperative MRI between 2014 and 2019 at Tampere University Hospital, Finland. Patients were divided into two groups: \"No incidental MRI findings\" and \"Incidental MRI findings\" with the latter leading to further imaging and biopsies. Surgical approaches and the time delay between diagnosis and surgery were compared. Tumor sizes estimated by MRI, mammography, ultrasound, and histopathology were assessed for correlation.</p><p><strong>Results: </strong>Incidental MRI findings were identified in 22% of patients, with a higher mastectomy rate in \"Incidental MRI findings\" (65.0%) group compared to the \"No incidental MRI findings\" (41%) group. Despite the higher mastectomy rate in the \"Incidental MRI findings\" group, most incidental findings were benign. The evaluated mean tumor size was largest on MRI (48 mm) compared to mammography (32 mm) and ultrasound (27 mm). MRI was found to overestimate tumor size, unlike mammography and ultrasound. No significant difference in the delay between MRI and surgery was observed between the two groups.</p><p><strong>Conclusions: </strong>In DCIS, incidental findings on MRI were associated with higher mastectomy rate, but overtreatment or unnecessary mastectomies were not detected. MRI may assist surgical decision-making in patients with pure DCIS.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"211-217"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147318678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of an ultra-low dose of superparamagnetic iron oxide on postoperative breast MRI artifacts and skin discoloration in patients with breast cancer.","authors":"Nushin Mirzaei, Fredrik Wärnberg, Pontus Zaar, Micael Oliveira Diniz, Andreas Karakatsanis, Henrik Leonhardt, Roger Olofsson Bagge","doi":"10.1177/14574969251387495","DOIUrl":"10.1177/14574969251387495","url":null,"abstract":"<p><strong>Background: </strong>Superparamagnetic iron oxide (SPIO) nanoparticles are non-inferior as a tracer for sentinel lymph node biopsy (SLNB) detection in breast cancer patients compared to the standard radioactive tracer (technetium-99m, Tc^99m) with or without blue dye (Patent blue V^®, BD). Sentinel lymph node (SLN) detection has been successful using an ultra-low dose of 0.1 mL SPIO injected intradermally in patients with breast cancer, and this study aims to assess the potential reduction of SPIO-related skin discoloration and breast magnetic resonance imaging (MRI) artifacts at 6 and 12 months after breast-conserving surgery using the ultra-low dose of SPIO.</p><p><strong>Method: </strong>Skin discoloration and MRI artifact were pre-planned endpoints in the prospective MAGSNOW feasibility study. MRI follow-ups were scheduled 6 and 12 months after surgery, and MRI artifacts were classified into six grades. SPIO-induced skin discoloration was assessed at baseline, 1, 6, and 12 months by photography.</p><p><strong>Results: </strong>Thirty-six patients had 6- and 12-month MRI follow-up performed, revealing no MRI artifacts impairing breast assessment. At 12 months, 75.0% (27/36) of the patients had minimal MRI artifacts, primarily in the subcutaneous tissue, or <5 mm in the fibro-glandular tissue. At 12 months, 54% (27/50) of the patients had a skin discoloration with a median area of 0.79 cm² (interquartile range (IQR) 0.14-1.41).</p><p><strong>Conclusion: </strong>An ultra-low dose of SPIO may offer a solution to the concerns of MRI artifacts and skin discoloration associated with the present recommended dose of 1-2 mL of SPIO.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"203-210"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145497383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A scoping literature review on the surgical management of splenic flexure tumors.","authors":"Zoe Garoufalia, Sameh H Emile, Nir Horesh, Michal Perets, Noam Kahana, Steven D Wexner","doi":"10.1177/14574969251387491","DOIUrl":"10.1177/14574969251387491","url":null,"abstract":"<p><strong>Background: </strong>Splenic flexure cancer is relatively uncommon, accounting for less than 5% of all colorectal cancers with challenging surgical treatment because of their unique anatomic location, blood supply, and lymphatic drainage. The aim of this review was to evaluate the current landscape of surgical management of splenic flexure tumors splenic flexure tumors, assessing available evidence and highlighting areas for future research.</p><p><strong>Methods: </strong>Scoping review of literature up to March 2025, reported according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines.</p><p><strong>Results: </strong>Current evidence on the surgical management of splenic flexure tumors relies on analysis of retrospective studies, which are limited by heterogeneity in definitions and significant selection bias. Based on the available evidence, both extended and limited resections appear to result in similar short- and long-term outcomes as well as pathologic outcomes in elective, non-obstructive settings. The certainty of evidence for these outcomes, though, is very low, precluding any safe recommendations for any procedure. Regarding the extent of lymph node dissection, there is no conclusive evidence favoring D3 or central vascular ligation over D2 lymphadenectomy. Minimally invasive surgery is considered safe in experienced hands. Personalized preoperative planning is important due to the highly variable vascular anatomy at the splenic flexure.</p><p><strong>Conclusion: </strong>Surgical treatment of splenic flexure tumors remains controversial due to the lack of high-quality prospective data. No single approach can currently be recommended for all cases. Until randomized trials provide definitive guidance, individualized surgical strategies that respect embryologic planes, ensure oncological adequacy, and account for anatomic variability should be pursued. Future directions should focus on standardizing definitions, improving pathologic evaluation of mesocolic integrity, and designing randomized trial to avoid selection bias.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"226-234"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Crohn's disease: Risk of surgery among newly diagnosed patients.","authors":"Kristi Kontola, Pia Oksanen, Heini Huhtala, Ilona Helavirta, Tuire Ilus","doi":"10.1177/14574969261423004","DOIUrl":"10.1177/14574969261423004","url":null,"abstract":"<p><strong>Background and objective: </strong>Medical treatment and treatment goals for Crohn's disease (CD) have evolved over the past 20 years. The aim of the study was to assess the cumulative risk of surgery in newly diagnosed CD patients in all age groups over this period.</p><p><strong>Methods: </strong>Recently diagnosed CD patients were retrieved from the registry of the Social Insurance Institution of Finland and data on surgeries from the Finnish Institute for Health and Welfare. The focus was on major intestinal surgery. Patients were stratified according to the year of diagnosis into three study periods: 2000-2006, 2007-2013, and 2014-2020.</p><p><strong>Results: </strong>We identified 11,329 recently diagnosed CD patients, of whom 1959 underwent surgery. The cumulative risks of surgery were 8.2%, 13.8%, and 18.7% at 1, 5, and 10 years post diagnosis, respectively. Surgical treatment was more frequent in male patients (IRR = 1.20, CI = 1.10-1.32). The pediatric group (age < 20 years) and the elderly (age ⩾ 60 years) had a higher risk of surgery (IRR = 1.24, CI = 1.10-1.39 and IRR = 1.20, CI = 1.07-1.34, respectively) compared to adults (aged 20-59 years at diagnosis). Adults had a lower risk of undergoing surgery in later periods than in the first period (IRR = 0.55, CI = 0.49-0.62). The pediatric group demonstrated reduction only in the last study period (IRR = 0.25, CI = 0.18-0.34). Elderly patients had a stable risk (IRR = 1.04, CI = 0.82-1.31) with 5-year risk increasing in the last period (IRR = 1.45, CI = 1.08-1.96).</p><p><strong>Conclusions: </strong>The risk of surgery among patients with newly diagnosed Crohn's disease is declining. The risk was also decreasing in the pediatric population, whereas in the elderly it remained stable or increased.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"163-168"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validation of the reporting of local recurrence of rectal cancer in the Swedish ColoRectal Cancer Registry (SCRCR).","authors":"Sophia Waldenstedt, Eva Haglind, Sebastian K Collet, Eva Angenete","doi":"10.1177/14574969261421723","DOIUrl":"10.1177/14574969261421723","url":null,"abstract":"<p><strong>Background and aims: </strong>The Swedish ColoRectal Cancer Registry (SCRCR) includes data on patients with rectal cancer in Sweden with a coverage rate of 98.5%. Variables on primary diagnosis and treatment have good validity, but the validation of oncological outcomes such as local recurrence is lacking. Since data from the SCRCR are used widely in research and for clinical evaluation, with local recurrence as an important outcome, this study aimed to validate the registration of local recurrence of rectal cancer in the SCRCR.</p><p><strong>Methods: </strong>All patients registered with a diagnosis of rectal cancer in 2016 and 2017 who underwent an abdominal resection of the tumor were identified in the SCRCR. Medical records were reviewed and compared to the data registered in the SCRCR.</p><p><strong>Results: </strong>A total of 2828 patients were included, of which 166 patients (5.9%) were diagnosed with local recurrence according to medical records within the study period. Of these, 94/166 (57%) were registered with local recurrence in the SCRCR. Patients with non-reported local recurrence more often had concurrent metastases and/or were treated with palliative intent. There were 17 patients reported with local recurrence in the SCRCR without local recurrence identified in the medical records.</p><p><strong>Conclusion: </strong>There was a significant underreporting of local recurrence in the SCRCR. Ambiguities in the definition of local recurrence as well as disregarding patients with concurrent metastatic disease probably contributed to the underreporting. Clarifying the definition of local recurrence and stressing the importance of reporting local recurrence regardless of metastatic disease or palliative treatment may improve data accuracy.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"155-162"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}